semaglutide compounding fda news Some doctors are embracing compounded versions of popular weight loss drugs Buying semaglutide online? Here's what

Injectable business as usual

The generic GLP-1 approval from the US Food and Drug Administration (FDA) is for Teva Pharmaceuticals version of Novo Nordisks injectable Saxenda (liraglutide)

Suitability for Weight Loss Medications In Lugoff, medical weight loss medications typically benefit adults with a BMI of 30 or higher or those with a BMI of 27 and additional weight-related health conditions

Australians should not use these products and should seek advice from their trusted healthcare professional. Despite previous warnings, the TGA said it is seeing increasing imports, online promotion and supply of unapproved peptides in Australia labelling their use a growing public health concern